Global Live Attenuated Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

August 2018 | 123 pages | ID: GB45598E65DGEN
GlobalInfoResearch

Abstracts

An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or 'live'). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by 'killing' the virus (inactivated vaccine).

SCOPE OF THE REPORT:

This report focuses on the Live Attenuated Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.

The worldwide market for Live Attenuated Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• GlaxoSmithKline
• Merck
• Pfizer
• Astellas Pharma
• Johnson & Johnson
• CSL
• Sanofi
• Serum Institute Of India

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Bacterial
• Viral

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Research Institutes
• Others

There are 15 Chapters to deeply display the global Live Attenuated Vaccines market.

Chapter 1, to describe Live Attenuated Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Live Attenuated Vaccines, with sales, revenue, and price of Live Attenuated Vaccines, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Live Attenuated Vaccines, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Live Attenuated Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Live Attenuated Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Live Attenuated Vaccines Introduction
1.2 Market Analysis by Type
  1.2.1 Bacterial
  1.2.2 Viral
1.3 Market Analysis by Applications
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Research Institutes
  1.3.4 Others
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 GlaxoSmithKline
  2.1.1 Business Overview
  2.1.2 Live Attenuated Vaccines Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 GlaxoSmithKline Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
  2.2.1 Business Overview
  2.2.2 Live Attenuated Vaccines Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Merck Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
  2.3.1 Business Overview
  2.3.2 Live Attenuated Vaccines Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Pfizer Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Astellas Pharma
  2.4.1 Business Overview
  2.4.2 Live Attenuated Vaccines Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Astellas Pharma Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
  2.5.1 Business Overview
  2.5.2 Live Attenuated Vaccines Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Johnson & Johnson Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 CSL
  2.6.1 Business Overview
  2.6.2 Live Attenuated Vaccines Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 CSL Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi
  2.7.1 Business Overview
  2.7.2 Live Attenuated Vaccines Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Sanofi Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Serum Institute Of India
  2.8.1 Business Overview
  2.8.2 Live Attenuated Vaccines Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Serum Institute Of India Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL LIVE ATTENUATED VACCINES SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Live Attenuated Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Live Attenuated Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Live Attenuated Vaccines Manufacturer Market Share in 2017
  3.3.2 Top 6 Live Attenuated Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL LIVE ATTENUATED VACCINES MARKET ANALYSIS BY REGIONS

4.1 Global Live Attenuated Vaccines Sales, Revenue and Market Share by Regions
  4.1.1 Global Live Attenuated Vaccines Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Live Attenuated Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
4.5 South America Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Live Attenuated Vaccines Sales and Growth Rate (2013-2018)

5 NORTH AMERICA LIVE ATTENUATED VACCINES BY COUNTRIES

5.1 North America Live Attenuated Vaccines Sales, Revenue and Market Share by Countries
  5.1.1 North America Live Attenuated Vaccines Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Live Attenuated Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico Live Attenuated Vaccines Sales and Growth Rate (2013-2018)

6 EUROPE LIVE ATTENUATED VACCINES BY COUNTRIES

6.1 Europe Live Attenuated Vaccines Sales, Revenue and Market Share by Countries
  6.1.1 Europe Live Attenuated Vaccines Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Live Attenuated Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
6.3 UK Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
6.4 France Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy Live Attenuated Vaccines Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC LIVE ATTENUATED VACCINES BY COUNTRIES

7.1 Asia-Pacific Live Attenuated Vaccines Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Live Attenuated Vaccines Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Live Attenuated Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
7.5 India Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Live Attenuated Vaccines Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA LIVE ATTENUATED VACCINES BY COUNTRIES

8.1 South America Live Attenuated Vaccines Sales, Revenue and Market Share by Countries
  8.1.1 South America Live Attenuated Vaccines Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Live Attenuated Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia Live Attenuated Vaccines Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA LIVE ATTENUATED VACCINES BY COUNTRIES

9.1 Middle East and Africa Live Attenuated Vaccines Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Live Attenuated Vaccines Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Live Attenuated Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa Live Attenuated Vaccines Sales and Growth Rate (2013-2018)

10 GLOBAL LIVE ATTENUATED VACCINES MARKET SEGMENT BY TYPE

10.1 Global Live Attenuated Vaccines Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Live Attenuated Vaccines Sales and Market Share by Type (2013-2018)
  10.1.2 Global Live Attenuated Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Bacterial Sales Growth and Price
  10.2.1 Global Bacterial Sales Growth (2013-2018)
  10.2.2 Global Bacterial Price (2013-2018)
10.3 Viral Sales Growth and Price
  10.3.1 Global Viral Sales Growth (2013-2018)
  10.3.2 Global Viral Price (2013-2018)

11 GLOBAL LIVE ATTENUATED VACCINES MARKET SEGMENT BY APPLICATION

11.1 Global Live Attenuated Vaccines Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Research Institutes Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)

12 LIVE ATTENUATED VACCINES MARKET FORECAST (2018-2023)

12.1 Global Live Attenuated Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 Live Attenuated Vaccines Market Forecast by Regions (2018-2023)
  12.2.1 North America Live Attenuated Vaccines Market Forecast (2018-2023)
  12.2.2 Europe Live Attenuated Vaccines Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Live Attenuated Vaccines Market Forecast (2018-2023)
  12.2.4 South America Live Attenuated Vaccines Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Live Attenuated Vaccines Market Forecast (2018-2023)
12.3 Live Attenuated Vaccines Market Forecast by Type (2018-2023)
  12.3.1 Global Live Attenuated Vaccines Sales Forecast by Type (2018-2023)
  12.3.2 Global Live Attenuated Vaccines Market Share Forecast by Type (2018-2023)
12.4 Live Attenuated Vaccines Market Forecast by Application (2018-2023)
  12.4.1 Global Live Attenuated Vaccines Sales Forecast by Application (2018-2023)
  12.4.2 Global Live Attenuated Vaccines Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Live Attenuated Vaccines Picture
Table Product Specifications of Live Attenuated Vaccines
Figure Global Sales Market Share of Live Attenuated Vaccines by Types in 2017
Table Live Attenuated Vaccines Types for Major Manufacturers
Figure Bacterial Picture
Figure Viral Picture
Figure Live Attenuated Vaccines Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Research Institutes Picture
Figure Others Picture
Figure United States Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure France Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure UK Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure China Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure India Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Live Attenuated Vaccines Revenue (Value) and Growth Rate (2013-2023)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Live Attenuated Vaccines Type and Applications
Table GlaxoSmithKline Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Live Attenuated Vaccines Type and Applications
Table Merck Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Live Attenuated Vaccines Type and Applications
Table Pfizer Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Live Attenuated Vaccines Type and Applications
Table Astellas Pharma Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Live Attenuated Vaccines Type and Applications
Table Johnson & Johnson Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Live Attenuated Vaccines Type and Applications
Table CSL Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Live Attenuated Vaccines Type and Applications
Table Sanofi Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Serum Institute Of India Basic Information, Manufacturing Base and Competitors
Table Serum Institute Of India Live Attenuated Vaccines Type and Applications
Table Serum Institute Of India Live Attenuated Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Live Attenuated Vaccines Sales by Manufacturer (2016-2017)
Figure Global Live Attenuated Vaccines Sales Market Share by Manufacturer in 2016
Figure Global Live Attenuated Vaccines Sales Market Share by Manufacturer in 2017
Table Global Live Attenuated Vaccines Revenue by Manufacturer (2016-2017)
Figure Global Live Attenuated Vaccines Revenue Market Share by Manufacturer in 2016
Figure Global Live Attenuated Vaccines Revenue Market Share by Manufacturer in 2017
Figure Top 3 Live Attenuated Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Live Attenuated Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Global Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Global Live Attenuated Vaccines Revenue and Growth Rate (2013-2018)
Table Global Live Attenuated Vaccines Sales by Regions (2013-2018)
Table Global Live Attenuated Vaccines Sales Market Share by Regions (2013-2018)
Table Global Live Attenuated Vaccines Revenue by Regions (2013-2018)
Figure Global Live Attenuated Vaccines Revenue Market Share by Regions in 2013
Figure Global Live Attenuated Vaccines Revenue Market Share by Regions in 2017
Figure North America Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Europe Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure South America Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure North America Live Attenuated Vaccines Revenue and Growth Rate (2013-2018)
Table North America Live Attenuated Vaccines Sales by Countries (2013-2018)
Table North America Live Attenuated Vaccines Sales Market Share by Countries (2013-2018)
Figure North America Live Attenuated Vaccines Sales Market Share by Countries in 2013
Figure North America Live Attenuated Vaccines Sales Market Share by Countries in 2017
Table North America Live Attenuated Vaccines Revenue by Countries (2013-2018)
Table North America Live Attenuated Vaccines Revenue Market Share by Countries (2013-2018)
Figure North America Live Attenuated Vaccines Revenue Market Share by Countries in 2013
Figure North America Live Attenuated Vaccines Revenue Market Share by Countries in 2017
Figure United States Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Canada Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Mexico Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Europe Live Attenuated Vaccines Revenue and Growth Rate (2013-2018)
Table Europe Live Attenuated Vaccines Sales by Countries (2013-2018)
Table Europe Live Attenuated Vaccines Sales Market Share by Countries (2013-2018)
Table Europe Live Attenuated Vaccines Revenue by Countries (2013-2018)
Figure Europe Live Attenuated Vaccines Revenue Market Share by Countries in 2016
Figure Europe Live Attenuated Vaccines Revenue Market Share by Countries in 2017
Figure Germany Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure UK Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure France Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Russia Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Italy Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Live Attenuated Vaccines Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Live Attenuated Vaccines Sales by Countries (2013-2018)
Table Asia-Pacific Live Attenuated Vaccines Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Live Attenuated Vaccines Sales Market Share by Countries 2017
Table Asia-Pacific Live Attenuated Vaccines Revenue by Countries (2013-2018)
Figure Asia-Pacific Live Attenuated Vaccines Revenue Market Share by Countries 2017
Figure China Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Japan Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Korea Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure India Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Southeast Asia Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure South America Live Attenuated Vaccines Revenue and Growth Rate (2013-2018)
Table South America Live Attenuated Vaccines Sales by Countries (2013-2018)
Table South America Live Attenuated Vaccines Sales Market Share by Countries (2013-2018)
Figure South America Live Attenuated Vaccines Sales Market Share by Countries in 2017
Table South America Live Attenuated Vaccines Revenue by Countries (2013-2018)
Table South America Live Attenuated Vaccines Revenue Market Share by Countries (2013-2018)
Figure South America Live Attenuated Vaccines Revenue Market Share by Countries in 2017
Figure Brazil Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Argentina Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Colombia Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Live Attenuated Vaccines Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Live Attenuated Vaccines Sales by Countries (2013-2018)
Table Middle East and Africa Live Attenuated Vaccines Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Live Attenuated Vaccines Sales Market Share by Countries in 2017
Table Middle East and Africa Live Attenuated Vaccines Revenue by Countries (2013-2018)
Table Middle East and Africa Live Attenuated Vaccines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Live Attenuated Vaccines Revenue Market Share by Countries in 2013
Figure Middle East and Africa Live Attenuated Vaccines Revenue Market Share by Countries in 2017
Figure Saudi Arabia Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure UAE Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Egypt Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure Nigeria Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Figure South Africa Live Attenuated Vaccines Sales and Growth Rate (2013-2018)
Table Global Live Attenuated Vaccines Sales by Type (2013-2018)
Table Global Live Attenuated Vaccines Sales Share by Type (2013-2018)
Table Global Live Attenuated Vaccines Revenue by Type (2013-2018)
Table Global Live Attenuated Vaccines Revenue Share by Type (2013-2018)
Figure Global Bacterial Sales Growth (2013-2018)
Figure Global Bacterial Price (2013-2018)
Figure Global Viral Sales Growth (2013-2018)
Figure Global Viral Price (2013-2018)
Table Global Live Attenuated Vaccines Sales by Application (2013-2018)
Table Global Live Attenuated Vaccines Sales Share by Application (2013-2018)
Figure Global Clinics Sales Growth (2013-2018)
Figure Global Research Institutes Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Live Attenuated Vaccines Sales, Revenue and Growth Rate (2018-2023)
Table Global Live Attenuated Vaccines Sales Forecast by Regions (2018-2023)
Table Global Live Attenuated Vaccines Market Share Forecast by Regions (2018-2023)
Figure North America Sales Live Attenuated Vaccines Market Forecast (2018-2023)
Figure Europe Sales Live Attenuated Vaccines Market Forecast (2018-2023)
Figure Asia-Pacific Sales Live Attenuated Vaccines Market Forecast (2018-2023)
Figure South America Sales Live Attenuated Vaccines Market Forecast (2018-2023)
Figure Middle East and Africa Sales Live Attenuated Vaccines Market Forecast (2018-2023)
Table Global Live Attenuated Vaccines Sales Forecast by Type (2018-2023)
Table Global Live Attenuated Vaccines Market Share Forecast by Type (2018-2023)
Table Global Live Attenuated Vaccines Sales Forecast by Application (2018-2023)
Table Global Live Attenuated Vaccines Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List